NEW YORK — Deepcell said on Monday that it has partnered with Nvidia to develop generative artificial intelligence technologies for single-cell research applications.
Through the collaboration, companies will use Nvidia's computing expertise and Clara suite of healthcare-focused computational platforms and software to build novel algorithms for cell morphology-based analysis applications that can be used in combination with tools such as Deepcell's recently launched REM-I high-dimensional cell analysis and sorting platform.
Additional terms of the deal were not disclosed.
"We see many possibilities for incorporating multimodal and generative AI into our platform and leveraging our proprietary database of billions of cell images to train additional AI models," Deepcell Cofounder, President, and Chief Technology Officer Mahyar Salek said in a statement. "Our relationship with Nvidia will help us accelerate such enhancements and bring these advancements to our customers."
Founded in 2017 as a spinout of Stanford University, Menlo Park, California-based Deepcell raised $73 million in Series B funding in early 2022.